![](https://pharmashots.com/public/default-image/default-730x400.png )
Alvogen Voluntary Recalls Nationwide Two Lots of Fentanyl Transdermal System Due to Product Mislabeling
Shots:
- Alvogen voluntarily nationwide recalled two lots of fentanyl transdermal system 12 mcg/h transdermal patches to the consumer level due to mislabeling on cartons labeled with 12 mcg/h containing 50 mcg/h patches that may results in life threatening or fatal respiratory depression
- The mislabeled products are manufactured by 3M Drug Delivery Systems. The mislabeled fentanyl transdermal patches lots include: Lot 180060- 12 mcg/h- expiry date May’20; Lot 180073- 12 mcg/h- expiry date Jun’20. The recall is being conducted under the knowledge of the US FDA
- The fentanyl transdermal patches are indicated for the management of pain in opioid tolerant patients. Fentanyl is also used as a recreational drug- often mixed with heroin or cocaine and has rapid effect which last< 2hrs.
Ref: Alvogen | Image: Alvogen
Click here to read the full press release
![](https://pharmashots.com/public/images/Senior-2023-08-17-64ddc3af74ec4.png)
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com